Home   ->   news   ->   Press Releases

Press Releases

uXi PharmaTech Strengthens Senior Management Team With Dr. Naruhito Masai

February 02, 2005 - Shanghai, China - WuXi PharmaTech, a leading chemistry-based R&D service company based in Shanghai, China, recently announced an appointment of Dr. Naruhito Masai as Vice President of Business Development in Japan.

"I am very excited to have added Dr. Masai to our senior management team. Dr. Masai is a great asset for us to expand WuXi PharmaTech business in Japan and other regions," said Dr. Ge Li, Chief Executive Officer and Chairman of WuXi PharmaTech.

Dr. Masai has extensive experience in the Japan pharmaceutical and fine chemical industries. He started his professional career at Sumitomo Chemicals where he took various positions with increasing responsibilities. As a senior research scientist and later a management director, he expanded a number of pharmaceutical businesses that were important to the success of Sumitomo. Also under his leadership, Sumika Fine Chemicals, a subsidiary of Sumitomo, became one of the finest fine chemical and API manufactures in the world. Prior to joining Wuxi PharmaTech, Dr. Masai was the General Manger of Global Sales at Sumika Fine and he was also an active lecturer on the business of custom synthesis. He has a Ph.D. in Organic Synthetic and Physical Organic Chemistry from Tokyo University, Japan and a B.Sc. in chemistry from Kyoto University, Japan. He also worked with Dr. Nicolas Bodor, one of the best- regarded drug delivery system researchers, in the development of a novel delivery method for his post Ph.D. research in U.S.

About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top